Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Carter Bankshares, Inc.NASDAQ: CARE
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items turns positive
Q1 FY2026 other non-cash items was $190.56M, compared with -$2.82M a year earlier. Trailing-twelve-month other non-cash items was $203.19M.
Context
- Other non-cash items amounted to 0.9% of revenue in FY2025, up 0.3 pp from a year earlier.
- Other non-cash items increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other non-cash items holds near $190.56M or moves back toward the trailing-twelve-month quarterly average of $50.8M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- (2.27M) USD
- Year-over-year change
- -59.1%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.27M) | -59.1% |
| FY2024 | 2024-12-31 | (1.43M) | -109.8% |
| FY2023 | 2023-12-31 | 14.5M | +48.4% |
| FY2022 | 2022-12-31 | 9.77M | -65.4% |
| FY2021 | 2021-12-31 | 28.25M | — |
Other Non-Cash Items vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 other non-cash items of $203.19M is the 2nd largest of the 11 companies compared; the peer median is $1.44M.
- Its year-over-year change of +3968.1% is the highest of 11, against a peer median of -27.8%.
- Other non-cash items amounts to 63.5% of revenue for CARE, versus a peer median of 3.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $222.44M | +35.3% | +81.6% | 36.1% | |
| LTM Mar 2026 | $203.19M | +3968.1% | — | 63.5% | |
| LTM Mar 2026 | $21.57M | -419.8% | — | 11.4% | |
| LTM Mar 2026 | $20.71M | -1210.8% | — | 10.1% | |
| LTM Mar 2026 | $13.65M | +1252.5% | +13.1% | 5.6% | |
| LTM Mar 2026 | $8.83M | -149.4% | — | 4.2% | |
| LTM Mar 2026 | $7.03M | +159.4% | -21.5% | 2.8% | |
| LTM Mar 2026 | $3.21M | -90.8% | — | 2.2% | |
| LTM Mar 2026 | $3.18M | +96.6% | +111.5% | 1.8% | |
| LTM Mar 2026 | $2.9M | -253.4% | — | 3.4% | |
| LTM Mar 2026 | $29K | +103.8% | -14.4% | 0.0% | |
| Peer median (excluding CARE) | $1.44M | -27.8% | +13.1% | 3.8% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| Deferred Income Tax | 4.82M | 4.25M | 2.47M | 3.21M | 2.82M |
| Stock-Based Compensation | 1.04M | 1.31M | 1.56M | 1.75M | 2.07M |
| Change in Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Other Non-Cash Items | 28.25M | 9.77M | 14.5M | (1.43M) | (2.27M) |
| Operating Cash Flow | 77.54M | 70.79M | 46.73M | 36.94M | 39.86M |
| Capital Expenditures | (8.48M) | (5.89M) | (9.8M) | (8.13M) | (8.06M) |
| Acquisitions (Net) | (73.92M) | 0 | 0 | 0 | 53.57M |
| Purchases of Investments | (466.65M) | (135.63M) | (24.94M) | (25.13M) | (63.68M) |
| Sales of Investments | 307.25M | 104.47M | 92.22M | 81.41M | 115.93M |
| Other Investing Activities | 135.45M | (345.02M) | (364.5M) | (116.55M) | (253.68M) |
| Investing Cash Flow | (106.36M) | (382.07M) | (307.01M) | (68.4M) | (155.91M) |
| Debt Repayment | (28M) | 173.55M | 194.98M | (323.4M) | 108.5M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (157K) | (42.93M) | (16.42M) | 0 | (20M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 92.83M | (50.27M) | 89.38M | 431.51M | 1.54M |
| Financing Cash Flow | 64.67M | 80.35M | 267.94M | 108.11M | 90.04M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 35.86M | (230.93M) | 7.66M | 76.64M | (26.01M) |
| Free Cash Flow | 69.05M | 64.9M | 36.93M | 28.81M | 31.81M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.